# Arterial Ablation for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities

> **NCT05363761** · PHASE1 · RECRUITING · sponsor: **Neurotronic, Inc.** · enrollment: 50 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Hypertension

## Interventions

- **COMBINATION_PRODUCT:** Neurotronic Infusion Catheter

## Key facts

- **NCT ID:** NCT05363761
- **Lead sponsor:** Neurotronic, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-19
- **Primary completion:** 2025-01
- **Final completion:** 2029-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05363761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05363761, "Arterial Ablation for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05363761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*